Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03341585
Other study ID # FVG005
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 7, 2018
Est. completion date December 15, 2020

Study information

Verified date December 2020
Source Vrije Universiteit Brussel
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether a specific airway clearance technique, l'Expiration Lente Prolongée (ELPr), induces or aggravates gastro-oesophageal reflux in infants under the age of one year. Infants referred to hospital for a multichannel intraluminal impedance pH (pH-MII) monitoring are included in this study. Participation is only possible after signing the informal consent by one of the parents.


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date December 15, 2020
Est. primary completion date December 15, 2020
Accepts healthy volunteers No
Gender All
Age group N/A to 365 Days
Eligibility Inclusion Criteria: - Infants under the age of one year and on suspicion of GOR who were referred for 24h impedance-pH monitoring are included in this study. Exclusion Criteria: - prematurity (gestational age less than 37 weeks), - the use of anti-reflux medication and reflux surgery (Nissen fundoplication)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
expiration lente prolongée
l'Expiration Lente Prolongée (ELPr) is a passive technique to enhance the expiration used in infants, obtained by a slow and increasing manual thoraco-abdominal pression applied at the end of a spontaneous expiration till the residual volume. The aim is to obtain a bigger expired volume compared to a normal expiration and drain the mucus out of the airways (Postiaux 2003). This technique has been invented by Guy Postiaux and is used in the Chest Physiotherapy (CPT).

Locations

Country Name City State
Belgium UZ Brussel Jette Brussels

Sponsors (1)

Lead Sponsor Collaborator
Vrije Universiteit Brussel

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary number of refluxes 20 minutes
See also
  Status Clinical Trial Phase
Completed NCT02128867 - Safety Study of Airway Clearance Techniques in Infants. N/A
Completed NCT00481949 - Assessment of Gastro-esophageal Reflux Using Endo-Flip vs Bravo N/A
Recruiting NCT03669874 - Endoscopic Fundoplication With MUSE System
Terminated NCT00222079 - Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy N/A
Not yet recruiting NCT05068089 - Health, Economic Analysis and Clinical Aspects of Patients With Neurological Disabilities in Enteral Nutrition With Dedicated Formula. The Role of Nissen's Fundoplication in the Management of Gastroesophageal Reflux
Not yet recruiting NCT03904004 - Pressure and Flow Study Before and After Treatments for EMD. The pFlow Study
Completed NCT01601379 - Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease. Phase 4
Not yet recruiting NCT05425771 - ARMA (Antireflux Mucosa Ablation) in Patients With Chronic Refractory Reflux Disease N/A
Completed NCT03306485 - Post Prandial High Resolution Impedance- Manometry
Not yet recruiting NCT02609620 - Safety & Initial Efficacy of the LunGuard PFT Sys. on Enteral-Fed, Sedated and Mechanically Ventilated Patients Peristaltic Feeding Tube N/A